A safe inhaled alkaline treatment that inhibits respiratory viral infections in a dose-dependent manner

J. Saunders (Indianapolis, United States of America), R. Relich (Indianapolis, United States of America), L. Smith (Indianapolis, United States of America), B. Gaston (Indianapolis, United States of America), M. Davis (Indianapolis, United States of America)

Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Session: Paediatric lung disease: novel mechanisms, methods and translational studies
Session type: Oral Presentation
Number: 1615

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Saunders (Indianapolis, United States of America), R. Relich (Indianapolis, United States of America), L. Smith (Indianapolis, United States of America), B. Gaston (Indianapolis, United States of America), M. Davis (Indianapolis, United States of America). A safe inhaled alkaline treatment that inhibits respiratory viral infections in a dose-dependent manner. 1615

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of efficacy of interferon inducer in treatment of the recurrent acute respiratory viral infections in children
Source: Annual Congress 2012 - Fungal, viral and other infections
Year: 2012


Analysis of serum cytokine levels before and after isoprinosine treatment in children with acute viral respiratory infections
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010

The respiratory burst of human neutrophils is inhibited in vitro by Montelukast
Source: Eur Respir J 2002; 20: Suppl. 38, 620s
Year: 2002

Telithromycin is highly efficacious in the treatment of lower respiratory tract infections
Source: Eur Respir J 2003; 22: Suppl. 45, 151s
Year: 2003

Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels
Source: Eur Respir J 2002; 19: 952-958
Year: 2002



High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery
Source: ERJ Open Res, 7 (2) 00060-2021; 10.1183/23120541.00060-2021
Year: 2021



RSV infection induces MDC production in respiratory epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 482s
Year: 2004

Distal respiratory tract viral infections in young children trigger a marked increase in alveolar mast cells
Source: ERJ Open Res, 4 (4) 00038-2018; 10.1183/23120541.00038-2018
Year: 2018



Efficacy of inductor of endogenous interferon's, cyclopheroni, in treatment of children with frequent acute respiratory infection (FARI)
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002



Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model
Source: Eur Respir J 2011; 38: 401-408
Year: 2011



The efficacy of antiviral therapy of acute respiratory infections in paediatric practice
Source: International Congress 2017 – New insights into paediatric respiratory infections
Year: 2017


Clinical and virusological effectiveness study of ultralow doses of antibodies to interferon-gamma in treatment of acute respiratory viral infections and influenza in children
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009

Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013

Increasing immunosuppression despite high load of respiratory viruses: Fludarabine as rescue treatment in alloreactive lung disease
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011

The role of viral and bacterial infections in asthma severity
Source: Annual Congress 2005 - PG3 - Asthma: natural history, risk factors and overall management
Year: 2005

LATE-BREAKING ABSTRACT: The histone-deacetylase-8 selective inhibitor PCI-34051 enhances IFN-λ production in vitro and reduces inflammation in mouse models of rhinoviral infection and rhinovirus-induced exacerbations of asthma in vivo
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD
Source: Eur Respir J, 50 (4) 1700451; 10.1183/13993003.00451-2017
Year: 2017



Defective endogenous antiviral mediator production in response to viral infection
Source: International Congress 2015 – Resolving inflammation
Year: 2015



Characterization of viral infections in stable and exacerbated COPD
Source: International Congress 2019 – Airway infection in COPD
Year: 2019